Abstract
SummaryMarginal zone lymphoma is a relatively rare disease with a usually indolent clinical course. In clinical terms, three major subtypes—i.e., extranodal, nodal, and splenic marginal zone lymphomas—are encountered, which have specific clinical features. Clinical progress, however, has been limited in recent years as they are mostly lumped together with follicular lymphoma under the term “indolent lymphomas” in clinical trials. A talk given at the 2024 Annual Meeting of the Austrian Society of Hematology and Oncology aimed to summarize clinically relevant topics and progress in the field of marginal zone lymphoma, which is summarized in the current article.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
